Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,769.50
Bid: 1,769.50
Ask: 1,770.00
Change: 8.50 (0.48%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,772.50
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 underperforms global peers on 3i drop, sterling gains

Thu, 14th Nov 2019 09:08

* FTSE 100 down 0.8%, FTSE 250 down 0.3%

* Burberry jumps after Q2 results

* 3i drops after H1 report

* FirstGroup marks worst day in more than a year
(Adds news items, updates to close)

By Shashwat Awasthi and Muvija M

Nov 14 (Reuters) - London's FTSE 100 underperformed its
major global peers on Thursday, suffering its steepest intra-day
drop so far this month as falls in private equity company 3i,
stocks trading ex-dividend and a stronger pound hammered the
exporter-heavy index.

The main index fell 0.8% with 3i Group hitting a
five-month low after striking a cautious tone about new
investment opportunities and as heavyweight components Sainsbury
, Shell and GSK traded without
dividend entitlement.

The mid-cap FTSE 250 was 0.3% lower, with transport
operator FirstGroup dropping nearly 20% on its worst day
since May 2018 after a bigger first-half loss due to a charge
related to its Greyhound bus line business in the U.S..

Dollar earners were among the top drags on the main bourse
as sterling strengthened on hopes that Conservatives will win a
majority in the December election and finally break the deadlock
surrounding Britain's departure from the European Union.

Luxury brand Burberry outperformed the index,
rising 3.4% as the popularity of designer Riccardo Tisci's
collections boosted quarterly sales and offset declines in Hong
Kong where trading was hit by ongoing protests.

A host of trigger points, including weak Chinese factory
output data, anxiety around U.S.-China trade, and political
uncertainty in the U.S. amid an impeachment inquiry into
President Donald Trump also weighed on sentiment globally.

Slowing Chinese factory output growth was another sign of
how Beijing's trade dispute with Washington was weighing on
demand. To that end, China said the countries were holding
in-depth discussions on a "phase one" trade agreement.

"If a deal doesn't go through in the next couple of weeks,
the optimism seen in financial markets will rapidly turn into
pessimism and I wouldn't be surprised to see a 5-10% correction
in equity markets," said Hussein Sayed, Chief Market Strategist
at FXTM.

"At this stage, markets are in a wait-and-see mode until
further developments emerge."

G4S lost 2.4% after Norway's central bank said the
country's wealth fund, the world's largest, can no longer invest
in the security services company because of the risk that it
contributes to, or is responsible for human rights violations.

Airport operator Stobart tumbled 5% on the
small-cap index after suspending its dividend and posting a
bigger first-half loss.
(Reporting by Shashwat Awasthi in Bengaluru; Editing by Kirsten
Donovan)

More News
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.